Detailed Narrative
Natural Color Conversion Opportunity
Sensient continues to prioritize the wholesale conversion of synthetic to natural colors in the United States, identifying it as the single largest opportunity in the company's history. The company is making significant investments globally to increase production capacity, optimize its product portfolio, and build a resilient supply chain for botanicals. These efforts are aimed at supporting a $1 billion natural color sales goal, with approximately $20 million in natural color conversion sales invoiced to date.
Titanium Dioxide Replacement
The company highlighted its 'Avalanche' portfolio, a range of clean-label alternatives to titanium dioxide (TiO2), a whitening agent facing increasing regulatory scrutiny globally. While TiO2 is technically considered a natural color, its replacement is a challenging program. This initiative addresses growing customer demand to remove TiO2 from products like baked goods, frostings, confections, and makeup, and is not yet factored into the $1 billion natural color sales goal.
Extrusion-Stable Natural Colors
Sensient also showcased its extrusion-stable natural color offerings, designed for maximum stability in high-heat or pressure processes, commonly used in products like breakfast cereals. This innovation supports CPG companies' commitments to remove synthetic dyes from such categories, further expanding the application scope for natural colors.
Customer Conversion Pace and Deadlines
Management expressed high confidence in the natural color conversion timeline, citing key deadlines like January 1, 2027 (Walmart's deadline for private label brands) and January 1, 2028 (broader market expectation). While the precise distribution of conversions is hard to predict📌, customers are committed and actively reformulating, test-marketing, and scaling up production. Competitive dynamics may accelerate conversions as companies seek to solidify their market position.
FDA Involvement in Color Approvals
The FDA is increasingly involved in approving new natural colors for food use, a process that is unique to colors and requires extensive testing and data. Management noted that while many natural colors are already approved, there is ongoing petitioning for new ones. The company actively engages with the FDA on submitting raw materials for color use, indicating a dynamic regulatory landscape.
Capital Allocation Strategy
Sensient's capital allocation prioritizes investments in natural color production capabilities and capacity, with full-year 2026 capital expenditures expected to be between $150 million and $170 million, and $225 million to $250 million allocated for natural color capital over the next couple of years. The company aims to significantly improve its ROIC to the mid-teens over the next few years and will evaluate sensible acquisition opportunities, but does not anticipate share buybacks at this time.